Maintenance Dose Conversion Between Oral Risperidone and Pallperidone Palmitate 1 Month: Practical Guidance Based on Pharmacokinetic Simulations

This resource was selected by SMI Adviser content partners and approved by the SMI Adviser clinical expert team for inclusion in the knowledge base.

This study provides clinicians with a practical guidance to establish suitable maintenance dose levels of PP1M and oral risperidone when transitioning patients from one formulation to another.

ACCESS THIS RESOURCE

  • Was this Helpful ?
  • YesNo

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Saved Posts

X